Sugi Predict

Sugi Predict / Compounds / SCHEMBL4295202

SCHEMBL4295202

SCHEMBL4295202

CC(C)(C)CC(=O)Nc1c(Cl)cc(C(=O)O)cc1Cl

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.61
▸ ADORA1 P30542 4/20 0.50
▸ ADORA2A P29274 3/20 0.50
▸ RAB9A P51151 3/20 0.43
▸ HPGD P15428 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ GAA P10253 2/20 0.43
▸ TTR P02766 1/20 0.43
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ KCNQ2 O43526 3/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ ADORA2B P29275 1/20 0.40
▸ PDK1 Q15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19179565 0.77 L3MBTL1 (0.57) L3MBTL1ADORA1ADORA2ARAB9AHPGD
SCHEMBL13668110 0.77 L3MBTL1 (0.56) L3MBTL1ADORA1ADORA2ARAB9AHPGD
SCHEMBL2231173 0.76 L3MBTL1 (1.00) L3MBTL1ADORA1ADORA2ARAB9AHPGD
SCHEMBL10471341 0.75 TTR (0.52) MAPTGAATTRMEN1KMT2A
SCHEMBL3095291 0.75 L3MBTL1 (0.58) L3MBTL1ADORA1ADORA2ARAB9AHPGD
SCHEMBL30795048 0.75 L3MBTL1 (0.58) L3MBTL1ADORA1ADORA2ARAB9AHPGD
SCHEMBL13668108 0.74 L3MBTL1 (0.54) L3MBTL1ADORA1ADORA2ARAB9AHPGD
SCHEMBL23518545 0.74 L3MBTL1 (0.57) L3MBTL1ADORA1ADORA2ARAB9AHPGD
SCHEMBL3192437 0.74 ADORA2A (0.88) L3MBTL1ADORA1ADORA2ARAB9AHPGD
SCHEMBL1001108 0.74 L3MBTL1 (0.78) L3MBTL1ADORA1ADORA2ARAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247593-A1 N-THIAZOL-2-YL-BENZAMIDE DERIVATIVES H. LUNDBECK A/S (DK) 2009-10-01 — — US disclosed
EP-1803455-A1 N-thiazol-2-yl-benzamide derivatives H.Lundbeck A/S (DK) 2007-07-04 — — EP disclosed
EP-1682129-B1 N-THIAZOL-2-YL-BENZAMIDE DERIVATIVES LUNDBECK & CO AS H (DK) 2007-02-21 — — EP disclosed
EP-1682129-A1 N-THIAZOL-2-YL-BENZAMIDE DERIVATIVES H. LUNDBECK A/S (DK) 2006-07-26 — — EP disclosed
US-20060154974-A1 N-thiazol-2-yl-benzamide derivatives H. LUNDBECK A/S (DK) 2006-07-13 — — US disclosed
WO-2005039572-A1 N-THIAZOL-2-YL-BENZAMIDE DERIVATIVES H. LUNDBECK A/S (DK) 2005-05-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247593-A1 N-THIAZOL-2-YL-BENZAMIDE DERIVATIVES ADORA2A, ADORA3, ADORA1 L3MBTL1 2628/4885ADORA1 3/4885ADORA2A 1/4885
US-20060154974-A1 N-thiazol-2-yl-benzamide derivatives ADORA2A, ADORA3, ADORA1 L3MBTL1 2628/4885ADORA1 3/4885ADORA2A 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.